Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 26, 2022

BUY
$32.6 - $53.05 $1.03 Million - $1.67 Million
31,500 New
31,500 $1.17 Million
Q4 2021

Jan 21, 2022

SELL
$36.77 - $90.91 $2.57 Million - $6.36 Million
-70,000 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$41.79 - $135.3 $2.93 Million - $9.47 Million
70,000 New
70,000 $4.35 Million
Q2 2021

Jul 30, 2021

SELL
$32.15 - $89.72 $1.61 Million - $4.5 Million
-50,200 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$7.09 - $87.95 $355,918 - $4.42 Million
50,200 New
50,200 $2.26 Million

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $66.2M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.